MENU
RGLS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Regulus Therapeutics (RGLS) Earnings Date & Reports

Regulus Therapeutics Inc is a biotechnology company focused on the development of microRNA therapies... Show more

A.I. Advisor
published Earnings

RGLS is expected to report earnings to rise 22.75% to -24 cents per share on May 08

Regulus Therapeutics RGLS Stock Earnings Reports
Q1'25
Est.
$-0.25
Q4'24
Missed
by $0.03
Q3'24
Missed
by $0.04
Q2'24
Missed
by $0.05
Q1'24
Missed
by $0.07
The last earnings report on March 13 showed earnings per share of -20 cents, missing the estimate of -17 cents. With 780.92K shares outstanding, the current market capitalization sits at 119.24M.
View a ticker or compare two or three
RGLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
4224 Campus Point Court
Phone
+1 858 202-6300
Employees
30
Web
https://www.regulusrx.com